Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Aditya Birla Sun Life Pharma and Healthcare Fund · Direct ✕Aditya Birla Sun Life Special Opportunities Fund · Direct ✕

Growth of ₹10,000

Basics

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseABSLABSL
Fund managersDhaval ShahDhaval Gala
AUM₹1,076 Cr₹1,273 Cr
NAV₹41.5400₹32.0800
NAV date20 Nov 202620 Nov 2026
History7.4 years6.1 years
Expense ratio1.0%1.2%
Stars★★★★★★★★★★
Growth Score80.8080.40

AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.

Returns

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
1 month+10.45%+5.87%
3 months+2.06%+2.82%
6 months+11.10%+13.60%
YTD+22.61%+11.27%
1 year+21.04%+11.74%
3 years (CAGR)+20.35%+19.82%
5 years (CAGR)+16.19%+14.31%
10 years (CAGR)——
Since launch+21.24%+21.06%

Risk

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
Volatility14.6%15.3%
Downside volatility8.5%9.4%
Sharpe0.950.87
Sortino1.631.42
Calmar1.281.12
Return / risk1.391.29
Deepest fall−20.46%−20.29%
Days to recover398378
Below its high−0.02%0.00%

Against benchmark

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
Alpha−0.72%+6.90%
Beta0.940.92
R²93.0%92.4%
Up capture91.8%113.6%
Down capture91.5%81.2%
Tracking error3.9%4.4%
Information ratio−0.391.45
Treynor0.140.13

Consistency

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
Best 1-year+72.90%+65.53%
Middle 1-year+18.02%+14.41%
Worst 1-year−15.55%−8.14%
1-year periods with a loss19.4%9.9%
Middle 3-year+19.92%+19.87%
Positive months61.1%63.9%
Best day+3.23%+4.06%
Worst day−2.91%−5.61%
Worst 5% day−1.28%−1.43%
Positive days54.9%55.1%
NAVs a year247247

SIP of ₹10,000 a month

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
5-year XIRR+19.85%+17.84%
5-year value₹9,93,026₹9,44,753
3-year XIRR+16.84%+16.15%
1-year XIRR+26.66%+20.04%

Fund facts

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
Launched20 Jun 20195 Oct 2020
Minimum investment₹1,000₹500
Exit load——
RiskometerVery highVery high
Registrar (RTA)CAMSCAMS
Fund managers——
Active SIPsnot publishednot published

From AMFI's scheme details and member pages. A dash means AMFI has not published it or it is not loaded, not a zero. AMFI lists fund managers per fund house, not per fund, and reports active SIPs only for the whole industry. The riskometer comes from AMFI's fund performance table, which does not answer automated readers, so it is blank until another source is agreed.

Holdings overlap i

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
Aditya Birla Sun Life Pharma and Healthcare Fund
Direct · filing Oct 2026
—5%
Aditya Birla Sun Life Special Opportunities Fund
Direct · filing Oct 2026
5%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Aditya Birla Sun Life Pharma and Healthcare Fund and Aditya Birla Sun Life Special Opportunities Fund

Overlap
4.9%
smaller weight of each shared stock, added up
Stocks in common
5
of 40 and 68
Weight in common
10% · 5%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
Common stockAditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities FundCounts toward overlap
Biocon Limited1.79%1.09%1.09%
Ajanta Pharma Limited4.17%1.05%1.05%
Anthem Biosciences Limited1.08%1.04%1.04%
Onesource Specialty Pharma Limited0.86%1.00%0.86%
Fortis Healthcare Limited2.39%0.81%0.81%
5 stocks10.3%5.0%4.9%

Only in Aditya Birla Sun Life Pharma and Healthcare Fund (35)

Torrent Pharmaceuticals Limited8.83%
Sun Pharmaceutical Industries Limited8.35%
Cipla Limited7.10%
Apollo Hospitals Enterprise Limited6.60%
Sai Life Sciences Limited4.54%
Aurobindo Pharma Limited4.50%
Dr. Lal Path Labs Limited3.90%
Mankind Pharma Limited3.56%
Emcure Pharmaceuticals Limited3.06%
Abbott India Limited3.05%
Lupin Limited2.89%
Gland Pharma Limited2.86%
IPCA Laboratories Limited2.69%
Divi's Laboratories Limited2.34%
Corona Remedies Ltd.2.31%
Dr. Reddy's Laboratories Limited1.85%
Procter & Gamble Health Limited1.83%
Alkem Laboratories Limited1.65%
Eris Lifesciences Limited1.59%
Jupiter Life Line Hospitals Limited1.55%
Metropolis Healthcare Limited1.54%
Piramal Pharma Limited1.53%
Thyrocare Technologies Limited1.49%
Vijaya Diagnostic Centre Limited1.04%
Manipal Health Enterprises Limited1.00%

and 10 smaller holdings (7.5% of the fund).

Only in Aditya Birla Sun Life Special Opportunities Fund (63)

Aditya Infotech Limited6.90%
Bharti Airtel Limited4.14%
Union Bank of India3.68%
ICICI Bank Limited3.09%
Meesho Limited2.98%
Billionbrains Garage Ventures Limited2.47%
Shriram Finance Limited2.47%
Spr Auto Technologies Limited2.41%
Axis Bank Limited2.11%
Bank Of Maharashtra2.06%
Infosys Limited1.92%
Navin Fluorine International Limited1.90%
Ambuja Cements Limited1.88%
Wheels India Limited1.86%
SS Retail Ltd.1.81%
Sedemac Mechatronics Ltd.1.80%
Carborundum Universal Limited1.79%
Coforge Limited1.66%
Persistent Systems Limited1.63%
Ujjivan Small Finance Bank Limited1.58%
Vedanta Aluminium Metal Limited1.56%
Indus Towers Limited1.53%
Varun Beverages Limited1.51%
RBL Bank Limited1.51%
Tata Motors Ltd1.50%

and 38 smaller holdings (34.3% of the fund).

Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.

Sectors and company size

Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Special Opportunities Fund
Large companies33.2%39.5%
Mid companies30.7%15.5%
Small companies33.0%36.5%
Top 10 holdings54.6%32.3%
Largest sectorPharmaceuticals & Biotechnology 76%Banks 14%

Search Growth